CLINICAL_TRIALS ClinicalTrials.gov record update

Evaluate Immunogenicity, Reactogenicity, Safety of GSK Biologicals' MenC-TT Vaccine (2 Formulations) Given With Infanrix Hexa® + GSK Biologicals' Hib MenC-TT Vaccine (2 Formulations) Given With Infanrix Penta® to Infants in Mths 3,4,5 of Life

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT00135486
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:36:25.896048+00:00
Published At: 2016-09-16T00:00:00+00:00
Record Updated At: 2016-09-16
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Infections, Meningococcal"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2016-09-16"
protocolSection.identificationModule.nctId: "NCT00135486"
protocolSection.identificationModule.officialTitle: "Evaluate Immunogenicity, Reactogenicity, Safety of GSK Biologicals\u0027 MenC-TT Vaccine (2 Formulations) Given With Infanrix Hexa\u00ae + GSK Biologicals\u0027 Hib MenC-TT Vaccine (2 Formulations) Given With Infanrix Penta\u00ae to Infants in Mths 3,4,5 of Life"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.